Year |
Citation |
Score |
2020 |
Xiao Y, Thakkar KN, Zhao H, Broughton J, Li Y, Seoane JA, Diep AN, Metzner TJ, von Eyben R, Dill DL, Brooks JD, Curtis C, Leppert JT, Ye J, Peehl DM, et al. The mA RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor. Proceedings of the National Academy of Sciences of the United States of America. PMID 32817424 DOI: 10.1073/Pnas.2000516117 |
0.361 |
|
2019 |
Vijayalakshmi K, Shankar V, Bain RM, Nolley R, Sonn GA, Kao CS, Zhao H, Tibshirani R, Zare RN, Brooks JD. Identification of Diagnostic Metabolic Signatures in Clear Cell Renal Cell Carcinoma Using Mass Spectrometry Imaging. International Journal of Cancer. PMID 31863456 DOI: 10.1002/Ijc.32843 |
0.307 |
|
2019 |
Xiao Y, Zhao H, Tian L, Nolley R, Diep AN, Ernst A, Fuh KC, Miao YR, von Eyben R, Leppert JT, Brooks JD, Peehl DM, Giaccia AJ, Rankin EB. S100A10 is a critical mediator of GAS6/AXL-induced angiogenesis in renal cell carcinoma. Cancer Research. PMID 31585940 DOI: 10.1158/0008-5472.Can-19-1366 |
0.338 |
|
2017 |
Zhao H, Ning S, Nolley R, Scicinski J, Oronsky B, Knox SJ, Peehl DM. The immunomodulatory anticancer agent, RRx-001, induces an interferon response through epigenetic induction of viral mimicry. Clinical Epigenetics. 9: 4. PMID 28149332 DOI: 10.1186/S13148-017-0312-Z |
0.314 |
|
2017 |
Zhao H, Ning S, Nolley R, Scicinski J, Oronsky B, Knox SJ, Peehl DM. Abstract 4358: The immunomodulatory anticancer agent RRx-001 induces a vaccine-like interferon response through epigenetic induction of viral mimicry Cancer Research. 77: 4358-4358. DOI: 10.1158/1538-7445.Am2017-4358 |
0.321 |
|
2016 |
Oronsky B, Paulmurugan R, Foygel K, Scicinski J, Knox SJ, Peehl D, Zhao H, Ning S, Cabrales P, Summers TA, Reid TR, Fitch WL, Kim MM, Trepel JB, Lee MJ, et al. RRx-001: A Systemically Non-Toxic M2-to-M1 Macrophage Stimulating and Prosensitizing Agent In Phase II Clinical Trials. Expert Opinion On Investigational Drugs. PMID 27935336 DOI: 10.1080/13543784.2017.1268600 |
0.313 |
|
2016 |
Zhao H, Nolley R, Chan AM, Rankin EB, Peehl DM. Cabozantinib inhibits tumor growth and metastasis of a patient-derived xenograft model of papillary renal cell carcinoma with MET mutation. Cancer Biology & Therapy. 0. PMID 27715452 DOI: 10.1080/15384047.2016.1219816 |
0.319 |
|
2016 |
Valta MP, Zhao H, Saar M, Tuomela J, Nolley R, Linxweiler J, Sandholm J, Lehtimäki J, Härkönen P, Coleman I, Nelson PS, Corey E, Peehl DM. Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancer. Clinical & Experimental Metastasis. PMID 26873136 DOI: 10.1007/S10585-016-9781-2 |
0.338 |
|
2016 |
Zhao H, Leppert JT, Peehl DM. A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data. Plos One. 11: e0146505. PMID 26814892 DOI: 10.1371/Journal.Pone.0146505 |
0.328 |
|
2015 |
Zhao H, Ning S, Scicinski J, Oronsky B, Knox SJ, Peehl DM. Epigenetic effects of RRx-001: a possible unifying mechanism of anticancer activity. Oncotarget. PMID 26657731 DOI: 10.18632/Oncotarget.6526 |
0.328 |
|
2015 |
Lai CY, Wen LL, Zhang Y, Luo SS, Wang QY, Luo YH, Chen R, Yang X, Rittmann BE, Zhao HP. Autotrophic antimonate bio-reduction using hydrogen as the electron donor. Water Research. 88: 467-474. PMID 26519630 DOI: 10.1016/J.Watres.2015.10.042 |
0.404 |
|
2015 |
Zhao H, Ning S, Scicinski J, Oronsky B, Knox S, Peehl DM. Abstract 3515: RRx-001: A double action systemically non-toxic epigenetic agent for cancer therapy Cancer Research. 75: 3515-3515. DOI: 10.1158/1538-7445.Am2015-3515 |
0.327 |
|
2014 |
Saar M, Zhao H, Nolley R, Young SR, Coleman I, Nelson PS, Vessella RL, Peehl DM. Spheroid culture of LuCaP 147 as an authentic preclinical model of prostate cancer subtype with SPOP mutation and hypermutator phenotype. Cancer Letters. 351: 272-80. PMID 24998678 DOI: 10.1016/J.Canlet.2014.06.014 |
0.362 |
|
2014 |
Ingels A, Zhao H, Thong AE, Saar M, Valta MP, Nolley R, Santos J, Peehl DM. Preclinical trial of a new dual mTOR inhibitor, MLN0128, using renal cell carcinoma tumorgrafts. International Journal of Cancer. Journal International Du Cancer. 134: 2322-9. PMID 24243565 DOI: 10.1002/Ijc.28579 |
0.302 |
|
2013 |
Zhao H, Thong A, Nolley R, Reese SW, Santos J, Ingels A, Peehl DM. Patient-derived tissue slice grafts accurately depict response of high-risk primary prostate cancer to androgen deprivation therapy. Journal of Translational Medicine. 11: 199. PMID 23985008 DOI: 10.1186/1479-5876-11-199 |
0.307 |
|
2013 |
Zhao H, Sun N, Young SR, Nolley R, Santos J, Wu JC, Peehl DM. Induced pluripotency of human prostatic epithelial cells. Plos One. 8: e64503. PMID 23717621 DOI: 10.1371/Journal.Pone.0064503 |
0.333 |
|
2013 |
Valta M, Zhao H, Ingels A, Thong A, Nolley R, Saar M, Peehl D. Abstract B9: Mouse model of primary human renal cell carcinoma metastasis to bone Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-B9 |
0.311 |
|
2013 |
Zhao H, Thong A, Nolley R, Reese S, Santos J, Ingels A, Peehl D. Abstract B32: Patient-derived tissue slice grafts of high-risk primary prostate cancer: An authentic preclinical model for synthetic lethality-based therapy Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Pms-B32 |
0.361 |
|
2012 |
Tian J, Zhao H, Nolley R, Reese SW, Young SR, Li X, Peehl DM, Knox SJ. Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 3366-76. PMID 22535156 DOI: 10.1158/1078-0432.Ccr-11-3179 |
0.312 |
|
2012 |
Zhao H, Thong A, Nolley R, Reese S, Santos J, Peehl D. Abstract A3: A tumorgraft model of castration-resistant primary prostate cancer Cancer Research. 72. DOI: 10.1158/1538-7445.Prca2012-A3 |
0.37 |
|
2011 |
Tian J, Zhao H, Nolley R, Reese S, Li X, Peehl D, Knox S. Abstract C129: Darinaparsin sensitizes solid tumors but not normal tissues to radiation. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-C129 |
0.311 |
|
2011 |
Tian J, Zhao H, Nolley R, Reese S, Young S, Li X, Peehl D, Knox S. Abstract B207: Darinaparsin is an anti-solid tumor cytotoxin in vivo. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-B207 |
0.347 |
|
2010 |
Brannon AR, Reddy A, Seiler M, Arreola A, Moore DT, Pruthi RS, Wallen EM, Nielsen ME, Liu H, Nathanson KL, Ljungberg B, Zhao H, Brooks JD, Ganesan S, Bhanot G, et al. Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns. Genes & Cancer. 1: 152-163. PMID 20871783 DOI: 10.1177/1947601909359929 |
0.309 |
|
2010 |
Zhao H, Nolley R, Chen Z, Peehl DM. Tissue slice grafts: an in vivo model of human prostate androgen signaling. The American Journal of Pathology. 177: 229-39. PMID 20472887 DOI: 10.2353/Ajpath.2010.090821 |
0.356 |
|
2010 |
Flamand V, Zhao H, Peehl DM. Targeting monoamine oxidase A in advanced prostate cancer. Journal of Cancer Research and Clinical Oncology. 136: 1761-71. PMID 20204405 DOI: 10.1007/S00432-010-0835-6 |
0.345 |
|
2010 |
Brannon AR, Reddy A, Seiler M, Arreola A, Chen S, Moore DT, Pruthi RS, Wallen EM, Nielsen ME, Liu H, Ljungberg B, Zhao H, Brooks JD, Ganesan S, Bhanot G, et al. Abstract 1996: Molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct subtypes and survival patterns Cancer Research. 70: 1996-1996. DOI: 10.1158/1538-7445.Am10-1996 |
0.333 |
|
2009 |
Zhao H, Flamand V, Peehl DM. Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells. Bmc Medical Genomics. 2: 55. PMID 19691856 DOI: 10.1186/1755-8794-2-55 |
0.332 |
|
2009 |
Zhao H, Zongming Ma, Tibshirani R, Higgins JP, Ljungberg B, Brooks JD. Alteration of gene expression signatures of cortical differentiation and wound response in lethal clear cell renal cell carcinomas. Plos One. 4: e6039. PMID 19557179 DOI: 10.1371/Journal.Pone.0006039 |
0.302 |
|
2009 |
Zhao H, Peehl DM. Tumor-promoting phenotype of CD90hi prostate cancer-associated fibroblasts. The Prostate. 69: 991-1000. PMID 19267366 DOI: 10.1002/Pros.20946 |
0.362 |
|
2008 |
Peehl DM, Coram M, Khine H, Reese S, Nolley R, Zhao H. The significance of monoamine oxidase-A expression in high grade prostate cancer. The Journal of Urology. 180: 2206-11. PMID 18804811 DOI: 10.1016/J.Juro.2008.07.019 |
0.34 |
|
2008 |
Zhao H, Nolley R, Chen Z, Reese SW, Peehl DM. Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cells. Differentiation; Research in Biological Diversity. 76: 820-30. PMID 18248494 DOI: 10.1111/J.1432-0436.2007.00263.X |
0.359 |
|
2007 |
Li TH, Zhao H, Peng Y, Beliakoff J, Brooks JD, Sun Z. A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells. Nucleic Acids Research. 35: 2767-76. PMID 17426117 DOI: 10.1093/Nar/Gkm198 |
0.327 |
|
2007 |
Zhao H, Brooks JD. Selenomethionine induced transcriptional programs in human prostate cancer cells. The Journal of Urology. 177: 743-50. PMID 17222674 DOI: 10.1016/J.Juro.2006.09.071 |
0.344 |
|
2007 |
Zhao H, Ramos CF, Brooks JD, Peehl DM. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues. Journal of Cellular Physiology. 210: 111-21. PMID 17044071 DOI: 10.1002/Jcp.20828 |
0.338 |
|
2006 |
Zhao H, Ljungberg B, Grankvist K, Rasmuson T, Tibshirani R, Brooks JD. Gene expression profiling predicts survival in conventional renal cell carcinoma. Plos Medicine. 3: e13. PMID 16318415 DOI: 10.1371/Journal.Pmed.0030013 |
0.301 |
|
2005 |
Gu Z, Rubin MA, Yang Y, Deprimo SE, Zhao H, Horvath S, Brooks JD, Loda M, Reiter RE. Reg IV: a promising marker of hormone refractory metastatic prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 2237-43. PMID 15788672 DOI: 10.1158/1078-0432.Ccr-04-0356 |
0.345 |
|
2005 |
Zhao H, Kim Y, Wang P, Lapointe J, Tibshirani R, Pollack JR, Brooks JD. Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines. The Prostate. 63: 187-97. PMID 15486987 DOI: 10.1002/Pros.20158 |
0.333 |
|
2005 |
Zhao H, Lai F, Nonn L, Brooks JD, Peehl DM. Molecular targets of doxazosin in human prostatic stromal cells. The Prostate. 62: 400-10. PMID 15378519 DOI: 10.1002/Pros.20161 |
0.345 |
|
2004 |
Zhao H, Langerød A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, Bukholm IK, Kåresen R, Botstein D, Børresen-Dale AL, Jeffrey SS. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Molecular Biology of the Cell. 15: 2523-36. PMID 15034139 DOI: 10.1091/Mbc.E03-11-0786 |
0.314 |
|
2004 |
Zhao H, Whitfield ML, Xu T, Botstein D, Brooks JD. Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells. Molecular Biology of the Cell. 15: 506-19. PMID 14617803 DOI: 10.1091/Mbc.E03-07-0501 |
0.354 |
|
2001 |
Zhao H, Nonet ML. A conserved mechanism of synaptogyrin localization. Molecular Biology of the Cell. 12: 2275-89. PMID 11514616 DOI: 10.1091/Mbc.12.8.2275 |
0.605 |
|
2000 |
Zhao H, Nonet ML. A retrograde signal is involved in activity-dependent remodeling at a C. elegans neuromuscular junction. Development (Cambridge, England). 127: 1253-66. PMID 10683178 |
0.601 |
|
1998 |
Nonet ML, Saifee O, Zhao H, Rand JB, Wei L. Synaptic transmission deficits in Caenorhabditis elegans synaptobrevin mutants. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 70-80. PMID 9412487 DOI: 10.1523/Jneurosci.18-01-00070.1998 |
0.614 |
|
Show low-probability matches. |